Clinical Trials Browser

Phase 1/2 × Osteosarcoma × apatinib × Clear all

NCT07479732 2026-03-18

Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Phase 1/2 Recruiting

Osteosarcoma